Skip to main content

Nanohybride Materials Based on Magnetite-Gold Nanoparticles for Diagnostics of Prostate Cancer: Synthesis and In Vitro Testing

We synthesized a fluorescence conjugate and modified magnetite-gold nanoparticles carrying prostate specific membrane antigen (PSMA) as the ligand. Analysis of their binding to human prostate cancer cell lines PC-3 (PSMA) and LNCaP (PSMA+) showed selective interaction of the synthesized conjugate and modified nanoparticles with LNCaP cells. These findings suggest that these nanoparticles can be used in tissue-specific magnetic-resonance imaging.

This is a preview of subscription content, access via your institution.


  1. Colombatti M, Grasso S, Porzia A, Fracasso G, Scupoli MT, Cingarlini S, Poffe O, Naim HY, Heine M, Tridente G, Mainiero F, Ramarli D. The prostate specific membrane antigen regulates the expression of IL-6 and CCL5 in prostate tumour cells by activating the MAPK pathways. PLoS One. 2009;4(2):e4608.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Etame AB, Diaz RJ, O’Reilly MA, Smith CA, Mainprize TG, Hynynen K, Rutka JT. Enhanced delivery of gold nanoparticles with therapeutic potential into the brain using MRI-guided focused ultrasound. Nanomedicine 2012;8(7):1133-1142.

    CAS  PubMed  PubMed Central  Google Scholar 

  3. Gao X, Cui Y, Levenson RM, Chung LW, Nie S. In vivo cancer targeting and imaging with semiconductor quantum dots. Nat. Biotechnol. 2004;22(8):969-976.

    Article  CAS  PubMed  Google Scholar 

  4. Hövels AM, Heesakkers RA, Adang EM, Jager GJ, Strum S, Hoogeveen YL, Severens JL, Barentsz JO. The diagnostic ac-curacy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis. Clin. Radiol. 2008;63(4):387-395.

    Article  PubMed  Google Scholar 

  5. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA: Cancer J. Clin. 201;61(2):69-90.

  6. Kireev I, Lakonishok M, Liu W, Joshi VN, Powell R, Belmont AS. In vivo immunogold labeling confirms large-scale chromatin folding motifs. Nat. Methods 2008;5(4):311-313.

    CAS  PubMed  Google Scholar 

  7. Kularatne SA, Wang K, Santhapuram HK, Low PS. Prostatespecific membrane antigen targeted imaging and therapy of prostate cancer using a PSMA inhibitor as a homing ligand. Mol. Pharm. 2009;6(3):780-789.

    Article  CAS  PubMed  Google Scholar 

  8. Linn MM, Ball RA, Maradiegue A. Prostate-specific antigen screening: friend or foe? Urol. Nurs. 2007;27(6):481-489.

    PubMed  Google Scholar 

  9. Nakajima T, Mitsunaga M, Bander NH, Heston WD, Choyke PL, Kobayashi H. Targeted, activatable, in vivo fluorescence imaging of prostate-specific membrane antigen (PSMA) positive tumors using the quenched humanized J591 antibodyindocyanine green (ICG) conjugate. Bioconjug. Chem. 2011;22(8):1700-1705.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Shibutani ST, Yoshimori T. A current perspective of autophagosome biogenesis. Cell Res. 2014;24(1):58-68.

    Article  CAS  PubMed  Google Scholar 

  11. Tse BW, Cowin GJ, Soekmadji C, Jovanovic L, Vasireddy RS, Ling MT, Khatri A, Liu T, Thierry B, Russell PJ. PSMA-targeting iron oxide magnetic nanoparticles enhance MRI of preclinical prostate cancer. Nanomedicine (Lond). 2015;10(3):375-386.

    Article  CAS  Google Scholar 

  12. Yigit MV, Moore A, Medarova Z. Magnetic nanoparticles for cancer diagnosis and therapy. Pharm. Res. 2012;29(5):1180-1188.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Yu H, Chen M, Rice PM, Wang SX, White RL, Sun S. Dumbbell-like bifunctional Au-Fe3O4 nanoparticles. Nano Lett. 2005;5(2):379-382.

    Article  CAS  PubMed  Google Scholar 

  14. Zhang H. Quantum dot-A10 RNA aptamer-doxorubicin conjugate. MICAD. 2008, Aug 25.

  15. Zhu Y, Sun Y, Chen Y, Liu W, Jiang J, Guan W, Zhang Z, Duan Y. In vivo molecular MRI imaging of prostate cancer by targeting PSMA with polypeptide-labeled superparamagnetic iron oxide nanoparticles. Int. J. Mol. Sci. 2015;16(5):9573-9587.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to A. E. Machulkin.

Additional information

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 161, No. 5, pp. 651-655, May, 2016

Rights and permissions

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Machulkin, A.E., Garanina, A.S., Zhironkina, O.A. et al. Nanohybride Materials Based on Magnetite-Gold Nanoparticles for Diagnostics of Prostate Cancer: Synthesis and In Vitro Testing. Bull Exp Biol Med 161, 706–710 (2016).

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI:

Key Words